Going beyond a new implant design, Nobel Biocare is redefining the market with its N1 implant system.

The total solution sees site preparation improve with the introduction of the OsseoShaper, a new innovative alternative to conventional drilling protocols. Experience gained from over 18 months of clinical evaluations with an early ambassador group on the Nobel Biocare N1 concept have already indicated promising results in terms of the method's effectiveness.

Fully embracing the new Mucointegration concept, the Xeal and TiUltra surfaces will be available on the Nobel Biocare N1 implant system from day one. With the help of their specially tailored surface chemistry and topography, the Nobel Biocare N1 TiUltra implants and Xeal abutments can thus benefit from optimised tissue integration.

Nobel Biocare N1 will be further integrated into the digital workflow with DTX Studio, giving dental professionals more opportunities to provide patients with shorter-time-teeth.

Nobel Biocare N1 will first become available to clinicians in CE markets later in 2019, followed by additional markets pending regulatory approval.

More information about Nobel Biocare N1 is available at www.nobelbiocare.com/n1.